InvestorsHub Logo

H2R

09/29/17 2:09 PM

#1122 RE: DorseyE #1116

Tuesday, October 3: RedHill Biopharma (NASDAQ:RDHL) to report Phase 2 data on IBS-D drug BEKINDA (ondansetron).

https://seekingalpha.com/news/3298423-key-healthcare-events-next-week

Me like the current trend :)